Biosafety and protective equipment for the prevention of
This pandemic, present in our country, according to its containment stage, implies the adoption of several sanitary measures. In any case, there are measures that are easy to adopt and that depend on each person, i.e., frequent hand washing with soap and water when coughing or sneezing, covering the mouth and nose with the bend of the elbow, avoiding touching the eyes, nose and mouth, keeping a social distance.
Phase 1: Preparation and Coordination: The milestone of this phase is the knowledge of the disease, after its declaration in other countries, as well as the preparation for the probable arrival of imported cases of coronavirus.
Phase 3 Community infection: In this stage, infection is local, that is, it occurs among people who have not gone to countries at risk or have not had contact with people who have traveled, since the virus is already in the community.
If, for any reason, a probable case by epidemiological link is tested RT-PCR for SARS-CoV-2 and it is positive, it must comply with an isolation. On the other hand, if the result is negative or indeterminate, the case will continue to be considered a probable case and must remain in isolation until 11 days from the date of onset of symptoms have elapsed.
National authorities are responsible for issuing the certificate. It could be issued, for example, by testing centers or health authorities, or directly through an e-health portal.
The digital version can be stored on a mobile device. Citizens can also request a paper version. Both will have a QR code containing essential information, as well as a digital signature to ensure that the certificate is authentic.
The European Commission has set up a gateway that allows certificate signatures to be verified throughout the EU. The certificate holder’s personal data does not have to be transmitted through the gateway, as it is not needed to verify the digital signature. The European Commission also helped member states to develop national software and applications for issuing, storing and verifying certificates and supported them in the necessary tests to join the gateway.
Under the current EU approach, travelers from third countries who are fully vaccinated with an EMA-licensed vaccine must be able to travel to the EU for any reason. EU Member States may also allow entry of those vaccinated with vaccines that have completed the WHO emergency use listing process.
How long does it take to get the appointment in Ciudad Juarez?
As of June 25, 2021, people coming from Mexico will be able to enter Germany if they are fully vaccinated against SARS-CoV-2, which allows them to travel as visitors or tourists.
With all this information, you can go to a doctor or a pharmacy to request a European digital certificate (including the QR code) that you can save in your cell phone for future reference. The Mexican Embassy in Germany has no authority to influence this matter.
All persons entering Germany by air (whether on a direct flight from Mexico or from another country of embarkation) must present one of the following documents to the authorities or airline staff prior to boarding their flight:
Regardless of the above, persons who do not have a certificate of vaccination or recovery from the disease, once in Germany must go directly to their place of accommodation (or residence) where they are required to undergo a ten-day quarantine.
ADMISSION TO BASIC EDUCATION (CONVOCATORIA 2021)
However, the dynamics of production and secretion of these antigens have not been established, so a negative result (at any stage of infection) cannot be used to rule out a case, and other criteria must be considered.
Considering that the different kits can have very variable sensitivity, it is important to be able to define the strategy for their use. A sensitivity of less than 80% may require PCR confirmation of negative cases. Sensitivities above 80% could be considered acceptable and a confirmatory PCR should not be performed in cases of a negative antigen test, unless epidemiological or clinical background makes it advisable.
The PCR test detects the fragment of the genetic material of the SARS-Cov2 virus. In contrast, the antigen test detects viral proteins (antigens). When a virus enters the body and causes an infection, antigens are produced.
The antibody test detects the presence of antibodies produced against the infection. This test does not look for the virus, but for the antibodies we have developed against it. Assays based on the detection of IgM and IgG antibodies can support outbreak investigations or seroprevalence studies.